FK 506: an immunosuppressant for the 1990s?
- 5 January 1991
- journal article
- review article
- Published by Elsevier
- Vol. 337 (8732) , 25-27
- https://doi.org/10.1016/0140-6736(91)93341-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prevention of spontaneous diabetes in BB rats with FK 506The Lancet, 1990
- FK506—ITS INFLUENCE ON ANTI-CLASS 1 MHC ALLOANTIBODY RESPONSES TO BLOOD TRANSFUSIONSTransplantation, 1990
- FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhoodThe Lancet, 1990
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- PROLONGATION OF CARDIAC XENOGRAFT SURVIVAL IN RATS TREATED WITH 15-DEOXYSPERGUALIN ALONE AND IN COMBINATION WITH FK506Transplantation, 1988
- Immunosuppressive effect of FK506 on collagen-induced arthritis in ratsClinical Immunology and Immunopathology, 1988
- STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATSTransplantation, 1987
- STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOGTransplantation, 1987